Form 990 for tax year 2022
Filed by GLOBAL COALITION FOR ADAPTIVE RESEARCH INC.
Totals
- Total revenue
- $35,373,148
- Total expenses
- $24,083,323
- Contributions and grants received
- $543,271
- Grants paid
- $0
- Program service revenue
- $34,345,933
- Investment income
- $483,944
- Other revenue
- $0
- Total assets, end of year
- $59,575,227
- Total liabilities, end of year
- $21,752,254
- Net assets or fund balances, end of year
- $37,822,973
- Program services expenses (Part IX)
- $22,992,068
- Management and general expenses
- $1,091,255
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $22,992,068
Program services were 95.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$543,271
-
2a · Program service revenue: TRIAL REVENUE
total $34,345,933 · related or exempt $34,345,933
-
3 · Investment income
total $483,944 · excluded $483,944
Functional expenses
Part IX, the statement of functional expenses.
-
5 · Compensation of officers, directors and key employees
total $2,264,602 · program services $2,002,135 · management and general $262,467
-
7 · Other salaries and wages
total $1,972,617 · program services $1,759,648 · management and general $212,969
-
8 · Pension plan contributions
total $64,617 · program services $57,128 · management and general $7,489
-
9 · Other employee benefits
total $194,891 · program services $172,303 · management and general $22,588
-
10 · Payroll taxes
total $227,593 · program services $201,215 · management and general $26,378
-
11b · Fees: legal
total $88,405 · program services $39,810 · management and general $48,595
-
11c · Fees: accounting
total $38,752 · management and general $38,752
-
11f · Fees: investment management
total $7,108 · management and general $7,108
-
11g · Fees: other
total $18,685,932 · program services $18,629,731 · management and general $56,201
-
12 · Advertising and promotion
total $24,342 · program services $1,285 · management and general $23,057
-
13 · Office expenses
total $38,293 · program services $2,038 · management and general $36,255
-
14 · Information technology
total $107,683 · program services $5,686 · management and general $101,997
-
16 · Occupancy
total $5,272 · program services $278 · management and general $4,994
-
17 · Travel
total $99,653 · program services $70,555 · management and general $29,098
-
19 · Conferences, conventions and meetings
total $32,961 · program services $19,240 · management and general $13,721
-
23 · Insurance
total $230,602 · program services $31,016 · management and general $199,586
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $5,668,875 · end of year $7,218,662
-
2 · Savings and temporary cash investments
beginning of year $30,360,174 · end of year $0
-
4 · Accounts receivable
beginning of year $4,551,658 · end of year $3,062,438
-
9 · Prepaid expenses and deferred charges
beginning of year $160,168 · end of year $2,146,734
-
11 · Investments: publicly traded securities
beginning of year $0 · end of year $26,178,251
-
12 · Investments: other securities
beginning of year $0 · end of year $20,969,142
-
17 · Accounts payable and accrued expenses
beginning of year $3,469,813 · end of year $7,592,023
-
19 · Deferred revenue
beginning of year $8,910,607 · end of year $12,660,231
-
25 · Other liabilities
beginning of year $1,500,000 · end of year $1,500,000
-
27 · Net assets without donor restrictions
beginning of year $26,860,455 · end of year $37,822,973
Mission and programs · 2022
Mission
OUR MISSION IS TO LEAD THE DEVELOPMENT AND ONGOING MANAGEMENT OF CLINICAL TRIAL PLATFORMS TO ACCELERATE THE DISCOVERY AND DEVELOPMENT OF CURES FOR PATIENTS WITH RARE AND DEADLY DISEASES.
Activities or mission (Part I)
TO LEAD THE DEVELOPMENT AND ONGOING MANAGEMENT OF CLINICAL TRIAL PLATFORMS TO ACCELERATE THE DISCOVERY AND DEVELOPMENT OF CURES FOR PATIENTS WITH RARE AND DEADLY DISEASES.
-
GBM AGILE (GLIOBLASTOMA ADAPTIVE GLOBAL INNOVATIVE LEARNING ENVIRONMENT) IS UNIQUELY DESIGNED AS A LONG-STANDING PLATFORM WITH THE ABILITY TO TEST MULTIPLE THERAPIES AT THE SAME TIME AGAINST A COMMON CONTROL (OR STANDARD OF CARE). THE PURPOSE IS TO EVALUATE MULTIPLE INVESTIGATIONAL TREATMENTS FOR EITHER NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA TO DETERMINE IF ANY OF THESE STUDY TREATMENT(S) IMPROVE OVERALL SURVIVAL AS COMPARED TO STANDARD TREATMENTS.
Expenses $17,703,368 · Revenue $31,521,012
-
THE OBJECTIVE OF REMAP-COVID IS TO REDUCE MORTALITY AND MORBIDITY IN PATIENTS HOSPITALIZED WITH COVID-19 INFECTION BY QUICKLY GENERATING NEW EVIDENCE ON AVAILABLE AND NOVEL TREATMENTS. THROUGH PARTNERSHIPS WITH ACADEMIA, INDUSTRY AND MULTIPLE HEALTHCARE SYSTEMS, GCAR IS SPONSORING REMAP-COVID IN THE US WITH THE UNIVERSITY OF PITTSBURGH SERVING AS THE US REGIONAL COORDINATING CENTER FOR REMAP-CAP.
Expenses $3,270,151 · Revenue $2,331,100
-
CONSULTING, IN-DEVELOPMENT, AND SHORTER DURATION PROGRAMS IN OTHER RARE AND DEADLY DISEASE AREAS.
Expenses $2,018,549 · Revenue $493,821
As filed on the 2022 return.
Listed in Part VII
-
Brian Alexander MD MPHBRIAN ALEXANDER MD MPH
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Faramarz Yousefzadeh JD LlmFARAMARZ YOUSEFZADEH JD LLM
CHAIRMAN OF THE BOARD
- Total calculated
- $0
- Hours/week
- 1
-
Gary Gordon MD PhDGARY GORDON MD PHD
SENIOR MEDICAL ADVISOR AND DIRECTOR
- Total calculated
- $84,000
- From this org
- $84,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 4
-
John Frishkopf MmsJOHN FRISHKOPF MMS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Sujuan Ba PhDSUJUAN BA PHD
SECRETARY (THRU MID-DEC)/DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Timothy Cloughesy MDTIMOTHY CLOUGHESY MD
CHIEF MEDICAL OFFICER AND DIRECTOR
- Total calculated
- $120,000
- From this org
- $120,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 8
-
Wk Alfred Yung MDWK ALFRED YUNG MD
INVESTIGATOR CHINA-CHAIR, AGILE & DIRECTOR
- Total calculated
- $48,360
- From this org
- $48,360
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
-
Webster Cavenee PhDWEBSTER CAVENEE PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Matthew VivaMATTHEW VIVA
ASSOC DIRECTOR LEGAL/SECRETARY
- Total calculated
- $245,673
- From this org
- $225,992
- From related orgs
- $0
- Other
- $19,681
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $170,992
- Bonus
- $55,000
- Other
- $0
- Deferred
- $5,526
- Nontaxable benefits
- $14,155
- Filer's total
- $245,673
-
Meredith BuxtonMEREDITH BUXTON
CHIEF EXECUTIVE OFFICER & PRESIDENT
- Total calculated
- $748,256
- From this org
- $700,000
- From related orgs
- $0
- Other
- $48,256
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $450,000
- Bonus
- $250,000
- Other
- $0
- Deferred
- $12,750
- Nontaxable benefits
- $35,506
- Filer's total
- $748,256
-
Rachael ColemanRACHAEL COLEMAN
CFO/COO
- Total calculated
- $356,202
- From this org
- $351,567
- From related orgs
- $0
- Other
- $4,635
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $251,567
- Bonus
- $100,000
- Other
- $0
- Deferred
- $3,325
- Nontaxable benefits
- $1,310
- Filer's total
- $356,202
-
Ashley PowellASHLEY POWELL
EXECUTIVE DIRECTOR OF TRIAL OPS
- Total calculated
- $291,723
- From this org
- $274,663
- From related orgs
- $0
- Other
- $17,060
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $199,663
- Bonus
- $75,000
- Other
- $0
- Deferred
- $7,662
- Nontaxable benefits
- $9,398
- Filer's total
- $291,723
-
Robert MurrayROBERT MURRAY
CHIEF BUSINESS OFFICER
- Total calculated
- $370,388
- From this org
- $359,326
- From related orgs
- $0
- Other
- $11,062
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $249,326
- Bonus
- $110,000
- Other
- $0
- Deferred
- $9,567
- Nontaxable benefits
- $1,495
- Filer's total
- $370,388
-
Apoorva NelliAPOORVA NELLI
SENIOR CLINICAL SCIENTIST
- Total calculated
- $195,373
- From this org
- $177,074
- From related orgs
- $0
- Other
- $18,299
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $153,303
- Bonus
- $23,771
- Other
- $0
- Deferred
- $6,132
- Nontaxable benefits
- $12,167
- Filer's total
- $195,373
-
Rachel Rosenstein SissonRACHEL ROSENSTEIN SISSON
SR DIRECTOR OF ADMINISTRATION
- Total calculated
- $186,674
- From this org
- $172,500
- From related orgs
- $0
- Other
- $14,174
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $150,000
- Bonus
- $22,500
- Other
- $0
- Deferred
- $4,250
- Nontaxable benefits
- $9,924
- Filer's total
- $186,674
-
Sarah UntchSARAH UNTCH
ASSOC DIRECTOR TRIAL OPS
- Total calculated
- $220,972
- From this org
- $195,011
- From related orgs
- $0
- Other
- $25,961
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $150,011
- Bonus
- $45,000
- Other
- $0
- Deferred
- $6,400
- Nontaxable benefits
- $19,561
- Filer's total
- $220,972
-
Tracey RobertsTRACEY ROBERTS
ASSOC DIRECTOR, CLINICAL OPERATIONS
- Total calculated
- $209,835
- From this org
- $190,000
- From related orgs
- $0
- Other
- $19,835
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $160,000
- Bonus
- $30,000
- Other
- $0
- Deferred
- $6,400
- Nontaxable benefits
- $13,435
- Filer's total
- $209,835
-
Adam JohnsonADAM JOHNSON
SR MANAGER CLIN DATA MANAGEMENT
- Total calculated
- $165,646
- From this org
- $140,563
- From related orgs
- $0
- Other
- $25,083
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $105,563
- Bonus
- $35,000
- Other
- $0
- Deferred
- $4,720
- Nontaxable benefits
- $20,363
- Filer's total
- $165,646
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 12 May 2023
- IRS schema version
- 2022v5.0
- Source object
- 202301359349308010
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.